Affiliation:
1. Graduate School of Pharmaceutical Sciences, the University of Tokyo
Publisher
Pharmaceutical Society of Japan
Subject
Pharmaceutical Science,Pharmacology,General Medicine
Reference41 articles.
1. 1) Gyllensten H, Hakkarainen KM, Hägg S, Carlsten A, Petzold M, Rehnberg C, Jönsson AK. Economic impact of adverse drug events — a retrospective population-based cohort study of 4970 adults. PLOS ONE, 9, e92061 (2014).
2. 2) Lipton SA. Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults. NeuroRx, 1, 101–110 (2004).
3. 3) Hayashi H, Naoi S, Hirose Y, Matsuzaka Y, Tanikawa K, Igarashi K, Nagasaka H, Kage M, Inui A, Kusuhara H. Successful treatment with 4-phenylbutyrate in a patient with benign recurrent intrahepatic cholestasis type 2 refractory to biliary drainage and bilirubin absorption. Hepatol. Res., 46, 192–200 (2016).
4. 4) Abul-Husn NS, Kenny EE. Personalized medicine and the power of electronic health records. Cell, 177, 58–69 (2019).
5. 5) National Academies of Sciences. Engineering and MP and GAG-U-IRR. The Fourth Industrial Revolution: Proceedings of a Workshop—in Brief. National Academies Press, Washington, D.C. (2017).
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献